Where Are They Now? Christina Poh, MD Christina Poh, MD, is an associate clinical professor in the Division of Lymphoma and the director of the T Cell Lymphoma Program at City of Hope® Cancer Center, Duarte. When did you become…
Three Generations. One Mission. A Legacy That Will Last. Twenty years ago, Michael Werner received news that would forever change his family’s life. Diagnosed with follicular lymphoma (FL) and initially given a devastating prognosis, Michael was told he might have…
Meet the 2026 Lymphoma Research Mentoring Program Grantees The Lymphoma Research Foundation’s Lymphoma Scientific Research Mentoring Program (LSRMP) is a first-of-its-kind education and mentoring program for junior scientists who wish to focus on lymphoma and CLL research, whether in the…
The Beer, the Battle, and the Jorts: Chris Fedor’s Road Back From Lymphoma For Chris Fedor, life changed with a beer. It was September 2023. Chris was 25 years old, healthy, working, making plans, and moving through life like anyone…
Driven by Curiosity, Dedicated to Patients: The Journey of Dr. Peter Martin When Peter Martin, MD, looks back on the path that led him to become one of the world’s leading lymphoma specialists, he doesn’t point to a single defining…
The U.S. Food and Drug Administration (FDA) Approves Pirtobrutinib for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) October 2, 2026 – On October 2, 2026, the U.S. Food and Drug Administration (FDA) announced it approved pirtobrutinib (Jaypirca, Eli Lilly and Company)…
Lymphoma Research Foundation Announces International T-Cell Lymphomas Consortium New initiative will unite researchers worldwide to accelerate progress in rare and aggressive T-cell lymphomas. NEW YORK, Sept. 1 – The Lymphoma Research Foundation today announced the launch of the International T-cell…
The 13 Career Development Award and Postdoctoral Fellowship research grants include projects exploring numerous disease subtypes treatments, including rare disease states like T-cell lymphomas, as well as novel therapeutics.
New Research Brings a Powerful Shift in How We Understand Follicular Lymphoma For many people diagnosed with follicular lymphoma (FL), one message has long defined the experience: This is a cancer you can live with but not cure. A new…
Where Are They Now? Caitlin Gribbin, MD Caitlin Gribbin, MD, is an assistant professor of medicine within the division of Hematology and Oncology at Weill Cornell Medical Center. When did you become interested in the study of medicine? In lymphoma…
